Amgen Inc. CDR (AMGN) - Analysis

23.91000 CAD

0.18

0.76%

Last update Dec 12, 3:54 PM EST

Market closed

Day range

23.91000

23.75

23.99000

Previous close

23.73000

Open

23.99000

Access this stock data via API

Amgen Inc. CDR

23.91

0.18

0.76%

Analysis

Revenue estimate	Current year (Dec 2025)	Next year (Dec 2026)
Number of Analysts	30	29
Avg. estimate	35.28B	35.89B
Low estimate	34.53B	34.78B
High estimate	35.94B	37.41B
Last year sales	33.42B	35.28B
Sales growth	0.06	0.02

Access /revenue_estimate data via our API — starting from the Ultra plan.

EPS revisions	Current year (Dec 2025)	Next year (Dec 2026)
Up last 7 days	0	0
Up last 30 days	0	0
Down last 7 days	0	0
Down last 30 days	0	0

Access /eps_revisions data via our API — starting from the Ultra plan.

Analyst ratings

Firm	Date	Action
Raymond James	Sep 03, 2025	Assumes
Wolfe Research	Nov 15, 2024	Initiates
William Blair	May 03, 2024	Upgrade
Raymond James	Mar 28, 2024	Reinstates
SVB Leerink	May 23, 2022	Initiates
Wells Fargo	Dec 09, 2021	Initiates
Goldman Sachs	Dec 06, 2021	Initiates
BMO Capital	Nov 19, 2021	Initiates
Daiwa Capital	Sep 23, 2021	Downgrade
Atlantic Equities	Apr 28, 2021	Downgrade
UBS	Oct 28, 2020	Initiates
Raymond James	Oct 26, 2020	Upgrade
Bernstein	Oct 09, 2020	Downgrade
Raymond James	Mar 30, 2020	Upgrade
CFRA	Mar 13, 2020	Upgrade
Evercore ISI Group	Jan 21, 2020	Upgrade
Raymond James	Dec 24, 2019	Initiates
Morgan Stanley	Dec 17, 2019	Reinstates
SunTrust Robinson Humphrey	Nov 12, 2019	Initiates
B of A Securities	Oct 17, 2019	Reinstates
Credit Suisse	May 21, 2019	Initiates
BMO Capital	Mar 15, 2019	Initiates
Evercore ISI Group	Jan 28, 2019	Downgrade
Cantor Fitzgerald	Oct 01, 2018	Initiates
Atlantic Equities	Feb 05, 2018	Downgrade
Argus Research	Jan 23, 2018	Upgrade
Argus Research	Nov 01, 2017	Downgrade
RBC Capital	Sep 15, 2017	Initiates
BMO Capital	Jul 26, 2017	Downgrade
Deutsche Bank	Jun 23, 2017	Initiates

Access /analyst_ratings/light data via our API — starting from the Ultra plan.